Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • RegDesk Reviews & Ratings
    19 Ratings
    Company Website
  • Predict360 Reviews & Ratings
    18 Ratings
    Company Website
  • Auth0 Reviews & Ratings
    1,067 Ratings
    Company Website
  • optivalue.ai Reviews & Ratings
    4 Ratings
    Company Website
  • Pensero Reviews & Ratings
    2 Ratings
    Company Website
  • Grafana Cloud Reviews & Ratings
    859 Ratings
    Company Website
  • Reflectiz Reviews & Ratings
    33 Ratings
    Company Website
  • Assembled Reviews & Ratings
    272 Ratings
    Company Website
  • Adobe Experience Manager Reviews & Ratings
    1,876 Ratings
    Company Website
  • TrustInSoft Analyzer Reviews & Ratings
    6 Ratings
    Company Website

What is Rhizome AI?

Rhizome functions as a collaborative AI regulatory partner specifically tailored for teams working within the life sciences industry. Although conventional AI assistants boast impressive features, the unique demands of an AI tool tasked with guiding decisions on drugs or devices valued at over $100 million necessitate a more specialized approach. Our agents exclusively rely on factual information extracted from primary source documents, guaranteeing that their validation does not come from memory; we evaluate their effectiveness based on this standard, and there have been no reported inaccuracies in the last 18 months. The foundational databases that inform regulatory choices, such as Drugs@FDA, guidance documents, clinicaltrials.gov, and various standards, often present challenges for computer searches, with many existing solely as image-based PDFs. We have successfully developed methods to ingest and analyze this vast array of information, which includes over 75 health authority databases across more than 12 markets as of August 2026, a figure that continues to expand. This translates to more than 45 million documents that our agents can access and query in depth. Unlike a general assistant that may only consult 5 to 10 sources, Rhizome has the capability to analyze hundreds or even thousands of documents, as the crucial inquiry often posed is, "Have we missed a relevant precedent?" By employing this exhaustive methodology, we ensure that our users receive the most thorough and precise information available, ultimately empowering them to make informed decisions in their critical work. With a commitment to continuous improvement, we consistently enhance our processes to adapt to the evolving landscape of regulatory requirements.

What is LARVOL CLIN?

The LARVOL CLIN platform provides an extensive array of AI-powered data analytics and intelligence tailored for oncology and drug development professionals, integrating more than 100,000 cancer clinical trials alongside detailed outcomes, digitized Kaplan-Meier curves, forest plots, and real-time social media commentary from a community of over 5,000 oncologists. Users gain access to a cohesive interface that facilitates searches based on condition, intervention, or trial ID, enriched by expert-curated insights and visually appealing dashboards that enhance decision-making. Moreover, the platform includes functionalities such as conference tracking, comprehensive databases for biomarkers and diagnostics, and in-depth market intelligence reports collected from upwards of 25,000 sources, including regulatory agencies, clinical trial registries, and various scientific conferences. This tool is specifically designed to assist pharmaceutical and biotech teams in interpreting trial results, identifying trends, understanding mechanisms of action, and pinpointing biomarkers within disease pipelines, utilizing sophisticated search filters, heat maps, and real-time notifications. By adopting this all-encompassing strategy, users are ensured that they remain knowledgeable and prepared to make insightful choices amid the fast-paced advancements in the field. Ultimately, LARVOL CLIN stands out as an indispensable resource for those navigating the complexities of oncology research and drug development.

Media

No images available

Media

Integrations Supported

Alignable

Integrations Supported

Alignable

API Availability

Has API

API Availability

Has API

Pricing Information

$0/month/user
Free Version
Free Trial Offered?

Pricing Information

Pricing not provided
Free Version
Free Trial Offered?

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Company Facts

Organization Name

Rhizome AI

Date Founded

2023

Company Location

United States

Company Website

rhizomeai.com

Company Facts

Organization Name

LARVOL

Date Founded

2004

Company Location

United States

Company Website

www.larvol.com

Categories and Features

Categories and Features

Clinical Trial Management

21 CFR Part 11 Compliance
Document Management
Electronic Data Capture
Enrollment Management
HIPAA Compliant
Monitoring
Patient Database
Recruiting Management
Scheduling
Study Planning

Popular Alternatives

Freya Reviews & Ratings

Freya

Freyr Solutions

Popular Alternatives

PharmaPendium Reviews & Ratings

PharmaPendium

Elsevier
Mosio Reviews & Ratings

Mosio

Mosio, Inc.
Lawrbit Reviews & Ratings

Lawrbit

Lawrbit Global Compliance Network